A Recombinant OMV-Based Vaccine Elicits Potent Protective Immunity Against <i>Pseudomonas aeruginosa</i>.

Among these, the OMV PcrV group showed a trend toward higher CD4 + T-cell counts ( Figure 7 B), and the OMV + PcrV group showed slightly increased CD8 + T-cell counts ( Figure 7 C), but neither reached statistical significance.

also in 53,322 other papers

Some intergroup differences did not reach statistical significance, which may be attributed to the relatively high dispersion of individual data points within the experimental groups and biological heterogeneity in individual mouse responses. 3.5.

also in 111,027 other papers